StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –

Novartis Emerging Growth Markets by Quarter

Emerging Growth Markets ($M)

QuarterlyAnnual

Novartis Emerging Growth Markets: $3,783M in Q3 2026, up 10.6% from a year earlier.

Latest, Q3 2026
3,783
Period ended Sep 30, 2026
Change on a year earlier
+10.6%
3,420 in Q3 2025
History
30 quarters
Since Q2 2019
Sources
26
Documents cited below

Where the Q3 2026 figure comes from

“|| Of which in emerging growth markets | 3 783 | 3 420 | 11 | 8 | 26 | 25”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEmerging Growth Markets ($M)Year on yearSource
Q3 2026Sep 30, 20263,783+10.6%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20263,872+10.1%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 20263,851+8.1%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20253,476+18.1%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20253,420+3.3%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20253,517+5.0%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 20253,564+6.7%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20242,944+6.4%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20243,311+8.1%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20243,350+12.4%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 20243,341+15.1%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 20232,768+6.8%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20233,063+10.9%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 20232,981-56.4%Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 20232,903-14.2%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 20222,591-80.5%Novartis Form 6-K (0001370368-24-000007) ↗

Breakdown

What makes up emerging Growth Markets

Cite this data

StockData. (2026). Novartis Emerging Growth Markets ($M), quarterly Q2 2019–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-emerging-markets

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.